Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Heeyoung Won
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Journal of Cancer
Oncology
Related publications
Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-Pd-L1 Immune Checkpoint Inhibitor
Frontiers in Oncology
Cancer Research
Oncology
Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immune Checkpoint Inhibitor-Induced Fanconi Syndrome
Cureus
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020
Kidney360
Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice
Cancer immunology research
Cancer Research
Immunology
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients
Jurnal Respirasi
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Cancer Research
Cancer Research
Oncology